Bio Green Med Solution, Inc.
BGMSNasdaqCIK 1130166Consumer discretionaryFiscal year ends Dec 31
Reports and events: 425 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1620:05 ET | 8-K | 8.01 Other events | 0001493152-26-047396 |
| 2026-08-1420:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038393 |
| 2026-08-1401:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037902 |
| 2026-07-0120:05 ET | 8-K | 8.01 Other events | 0001493152-26-031542 |
| 2026-06-2210:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029452 |
| 2026-06-1016:47 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-028072 |
| 2026-06-0420:45 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027291 |
| 2026-05-1520:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023800 |
| 2026-05-1420:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023117 |
| 2026-04-2720:38 ET | DEF 14A | Proxy statementPeriod 2026-04-27 | 0001493152-26-019158 |
| 2026-04-1315:51 ET | 8-K | 8.01 Other events | 0001493152-26-016325 |
| 2026-03-3021:43 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013669 |
| 2026-03-3021:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013611 |
| 2026-03-1314:30 ET | 8-K | 3.01 Delisting notice | 0001493152-26-009991 |
| 2026-01-1221:05 ET | 8-K | 8.01 Other events | 0001493152-26-001848 |
| 2025-11-2622:01 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001493152-25-025179 |
| 2025-11-1323:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-022423 |
| 2025-11-1322:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022388 |
| 2025-11-1321:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022378 |
| 2025-11-0623:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-020920 |
| 2025-10-0713:01 ET | 8-K | 8.01 Other events | 0001493152-25-017224 |
| 2025-10-0713:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-25-017223 |
| 2025-09-2522:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-014840 |
| 2025-09-1720:53 ET | 8-K/A | 8.01 Other events | 0001493152-25-013902 |
| 2025-09-1620:05 ET | 8-K | 3.01 Delisting notice | 0001493152-25-013703 |
| 2025-09-1210:07 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-013123 |
| 2025-09-0515:53 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-026676 |
| 2025-09-0420:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-026571 |
| 2025-09-0210:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-026110 |
| 2025-08-2810:10 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-025752 |
| 2025-08-1401:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023648 |
| 2025-08-1321:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023607 |
| 2025-08-1310:17 ET | 8-K | 9.01 Financial statements and exhibits | 0001641172-25-023296 |
| 2025-08-0814:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-002135 |
| 2025-08-0423:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-002083 |
| 2025-07-3100:31 ET | S-1/A | Registration statement, amended | 0001641172-25-021610 |
| 2025-07-2820:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-021159 |
| 2025-07-2401:58 ET | S-1 | Registration statement | 0001641172-25-020764 |
| 2025-07-1613:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019834 |
| 2025-07-0710:04 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017906 |
| 2025-07-0213:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017479 |
| 2025-06-3020:28 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-017152 |
| 2025-06-2021:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-015874 |
| 2025-06-0321:00 ET | 8-K | 8.01 Other events | 0001641172-25-013479 |
| 2025-06-0320:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-013436 |
| 2025-05-1520:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010873 |
| 2025-05-1420:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010270 |
| 2025-05-0715:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-008988 |
| 2025-05-0620:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-008836 |
| 2025-04-2520:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-006201 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.